Advertisement

Topics

K2M expands MESA platform with FDA clearance for spine application

19:00 EDT 22 Sep 2016 | Medical Business Review

K2M Group Holdings announced at the Scoliosis Research Society (SRS) 51st Annual Meeting & Course in Prague, Czech Republic that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for screw and connector components toward a growing spine application for its MESA® Spinal System.

Original Article: K2M expands MESA platform with FDA clearance for spine application

NEXT ARTICLE

More From BioPortfolio on "K2M expands MESA platform with FDA clearance for spine application"

Quick Search
Advertisement
 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...